CJS Securities analyst Daniel Moore upgrades John Wiley & Sons (NYSE:WLY) from Market Perform to Market Outperform.
Unveiling Valuenomics: The Future of Digital Value
By Mohamed Ezeldin, Head of Tokenomics at Animoca Brands
CJS Securities Upgrades John Wiley & Sons to Market Outperform
CJS Securities analyst Daniel Moore upgrades John Wiley & Sons (NYSE:WLY) from Market Perform to Market Outperform.
Related Posts
Novavax Secures FDA Emergency Authorization For Adjuvanted Covid-19 Vaccine
The U.S. Food and Drug Administration (FDA) grants emergency use authorization (EUA) to Novavax’s (NASDAQ: NVAX) lead candidate Adjuvanted (NVX-CoV2373) COVID-19 Vaccine for individuals 18 years of age and over.
22nd Century Group And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 25 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Moderna’s Interim Earnings Beat Modestly, Uncertainty Looms Over 2023
Moderna Inc (NASDAQ:MRNA) reported interim FY22 COVID-19 vaccine sales of $18.4 billion against $18-19 billion forecasted in the Q3 earnings…